About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials in Chicago | 77 Studies

Clinical Trials LupusChicago

Lupus Clinical Trials in Chicago

Find 77 clinical trials for lupus near Chicago, Illinois. Connect with research centers in your area.

All Lupus trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 77 trials

CompletedA Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLETo compare the effect of RAYOS® versus immediate-release (IR) prednisone on fatigue as measured by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).NCT03098823·Los Angeles, California and 20 others CompletedSafety of Estrogens in Lupus: Birth Control PillsSafety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen.NCT00000420·Los Angeles, California and 14 others

Lupus Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedDouble-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.The primary objective of the study is to evaluate the safety, tolerability, and efficacy of 4 weeks intravenous treatment with Cpn10 in subjects with mild to moderate active SLE.NCT01838694·Miami, Florida and 5 others

WithdrawnStudy of Epratuzumab in Systemic Lupus ErythematosusEpratuzumab is an investigational antibody designed to help treat SLE. The purpose is to evaluate safety and long term efficacy in concert with standard SLE treatmentsNCT00382837·Birmingham, Alabama and 53 others

RecruitingA Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseThis is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune…NCT06925542·La Jolla, California and 15 others

CompletedA Study of LY2127399 in Participants With Systemic Lupus ErythematosusThe purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in participants with active SLE.NCT01196091·Birmingham, Alabama and 191 others

Not yet recruitingRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentThe purpose of this study is to provide continued access to anifrolumab to eligible participants who are continuing to derive clinical benefit from treatment at the end of a…NCT07691970·Los Angeles, California and 40 others

RecruitingPredictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)The PROMISSE Study is an observational study of 700 pregnant patients, enrolled at nine major clinical centers.NCT00198068·Chicago, Illinois and 9 others

CompletedSubcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus ErythematosusThe objective of this study is to evaluate and compare efficacy of 3 dose levels of PF-04236921 to placebo in subjects with generalized lupus using a measure called the Systemic…NCT01405196·Anniston, Alabama and 112 others

CompletedOmega-3 Replacement With Krill Oil in Disease Management of SLEA randomized, double-blind controlled, multicenter study in SLE patients given AKBM-3031or placebo for 24 weeks (randomized period) and followed by an open label extension (OLE)…NCT03626311·Birmingham, Alabama and 18 others

TerminatedPhysical Therapy for Systemic Lupus Erythematosus (SLE)The purpose of this study is to see if there is an improvement in patient's quality of life, pain, and fatigue after undergoing a supervised exercise program.NCT00152555·Chicago, Illinois

Active not recruitingA Study of Obexelimab in Patients With Systemic Lupus ErythematosusThis study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).NCT06559163·Peoria, Arizona and 109 others

CompletedAbatacept and Cyclophosphamide Combination Therapy for Lupus NephritisThis study is for individuals with lupus who have developed complications in their kidneys, or lupus nephritis.NCT00774852·Birmingham, Alabama and 22 others

CompletedA Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus ErythematosusThis is a Phase II, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rontalizumab compared with placebo in patients with…NCT00962832·Anniston, Alabama and 78 others

CompletedA Study of the Effect of XmAb®5871 in Patients With Systemic Lupus ErythematosusThe purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of…NCT02725515·La Jolla, California and 22 others

CompletedStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus ErythematosusThe primary objective of the study is to confirm the clinical efficacy of epratuzumab in the treatment of subjects with Systemic Lupus Erythematosus (SLE)NCT01262365·Birmingham, Alabama and 140 others

CompletedHealth-related Quality of Life Measure in Pediatric LupusTo examine the psychometric properties of a brief quality of life (QOL) instrument for use in pediatric systemic lupus erythematosus (SLE).NCT00280137·Los Angeles, California and 10 others

TerminatedNelfinavir in Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the body's immune system attacks different parts of the body.NCT02066311·Los Angeles, California and 7 others

TerminatedStudy of Epratuzumab in Systemic Lupus Erythematosus (SLE)The purpose of this study is to evaluate the safety and efficacy of Epratuzumab with standard treatments for patients with SLE.NCT00383214·Birmingham, Alabama and 59 others

CompletedActivity and Nutrition Trial in Lupus to Energize and RenewParticipants from the Fatigue and Lifestyle Physical Activity and SLE Study will be approached to enroll in a 6 week pilot intervention.NCT02281513·Chicago, Illinois

Page 1 of 4Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia